Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica D Levine

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Gynecologic Oncology Reports|April 27, 2023
Gastritis as an immunotherapy-related toxicity in the treatment of endometrial cancer: A case reportNidhi Goel, Monica D Levine, Laura M Chambers, et al.
Journal of Minimally Invasive Gynecology|July 31, 2020
Outcomes of Minimally Invasive versus Open Radical Hysterectomy for Early Stage Cervical Cancer Incorporating 2018 FIGO StagingMonica D Levine, Jubilee Brown, Erin K Crane, et al.
Gynecologic Oncology|July 23, 2022
Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerationsMonica D Levine, David A Barrington, Heather Hampel, et al.
Gynecologic Oncology Reports|April 17, 2023
Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: A case seriesCorinne A Calo, Monica D Levine, Morgan D Brown, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2023
The modified 5-item frailty index is a predictor of post-operative complications in vulvar cancer: a National Surgical Quality Improvement Program (NSQIP) analysisMonica D Levine, Ashley S Felix, Caitlin E Meade, et al.
Gynecologic Oncology Reports|April 21, 2023
Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?Monica D Levine, David M O'Malley, Paulina J Haight, et al.
American Journal of Obstetrics and Gynecology|December 27, 2022
Postoperative venous thromboembolism risk stratification in patients with uterine cancerVincent M Wagner, Rachael N Piver, Monica D Levine, et al.
Gynecologic Oncology Reports|March 13, 2023
Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancerRachael N Piver, Vincent M Wagner, Monica D Levine, et al.
Gynecologic Oncology Reports|February 23, 2024
Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State UniversityMonica D Levine, Vincent M Wagner, Courtney J Riedinger, et al.
Gynecologic Oncology|January 23, 2024
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistanceMonica D Levine, Heather Wang, Bhargavi Sriram, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Gynecologic Oncology Reports|April 27, 2023
Gastritis as an immunotherapy-related toxicity in the treatment of endometrial cancer: A case reportNidhi Goel, Monica D Levine, Laura M Chambers, et al.
Journal of Minimally Invasive Gynecology|July 31, 2020
Outcomes of Minimally Invasive versus Open Radical Hysterectomy for Early Stage Cervical Cancer Incorporating 2018 FIGO StagingMonica D Levine, Jubilee Brown, Erin K Crane, et al.
Gynecologic Oncology|July 23, 2022
Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerationsMonica D Levine, David A Barrington, Heather Hampel, et al.
Gynecologic Oncology Reports|April 17, 2023
Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: A case seriesCorinne A Calo, Monica D Levine, Morgan D Brown, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2023
The modified 5-item frailty index is a predictor of post-operative complications in vulvar cancer: a National Surgical Quality Improvement Program (NSQIP) analysisMonica D Levine, Ashley S Felix, Caitlin E Meade, et al.
Gynecologic Oncology Reports|April 21, 2023
Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?Monica D Levine, David M O'Malley, Paulina J Haight, et al.
American Journal of Obstetrics and Gynecology|December 27, 2022
Postoperative venous thromboembolism risk stratification in patients with uterine cancerVincent M Wagner, Rachael N Piver, Monica D Levine, et al.
Gynecologic Oncology Reports|March 13, 2023
Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancerRachael N Piver, Vincent M Wagner, Monica D Levine, et al.
Gynecologic Oncology Reports|February 23, 2024
Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State UniversityMonica D Levine, Vincent M Wagner, Courtney J Riedinger, et al.
Gynecologic Oncology|January 23, 2024
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistanceMonica D Levine, Heather Wang, Bhargavi Sriram, et al.
Pageof 2